Search

everythinglearnresearchcommunity

for

Search:↓

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

Metformin combined with dyne-35 increases ovulation and pregnancy rates in PCOS patients.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Platelet-rich plasma may improve embryo genetics in IVF.

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

Ovarian hemangioma is a rare, benign tumor that can be treated effectively with surgical removal.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Dermoscopy helps identify hair loss types for better hair transplant evaluation.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Hair loss in postmenopausal woman caused by ovarian issue.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Finasteride effectively reduces excess hair in women with certain conditions.

L-PRP and P-PRP reduced endometriosis in rats, but not significantly more than saline.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Blood tests confirmed a baby in the womb had a CMV infection.